- Home
- XGN vs IAE Comparison
XGN vs IAE Comparison
Compare XGN & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- IAE
- Stock Information
- Founded
- XGN 2002
- IAE 2007
- Country
- XGN United States
- IAE United States
- Employees
- XGN N/A
- IAE N/A
- Industry
- XGN Medical Specialities
- IAE Trusts Except Educational Religious and Charitable
- Sector
- XGN Health Care
- IAE Finance
- Exchange
- XGN Nasdaq
- IAE Nasdaq
- Market Cap
- XGN 72.3M
- IAE 67.9M
- IPO Year
- XGN 2019
- IAE N/A
- Fundamental
- Price
- XGN $5.65
- IAE $6.16
- Analyst Decision
- XGN Buy
- IAE
- Analyst Count
- XGN 1
- IAE 0
- Target Price
- XGN $7.00
- IAE N/A
- AVG Volume (30 Days)
- XGN 189.6K
- IAE 46.3K
- Earning Date
- XGN 11-12-2024
- IAE 01-01-0001
- Dividend Yield
- XGN N/A
- IAE 10.21%
- EPS Growth
- XGN N/A
- IAE N/A
- EPS
- XGN N/A
- IAE N/A
- Revenue
- XGN $55,751,000.00
- IAE N/A
- Revenue This Year
- XGN $6.74
- IAE N/A
- Revenue Next Year
- XGN $17.32
- IAE N/A
- P/E Ratio
- XGN N/A
- IAE N/A
- Revenue Growth
- XGN 8.00
- IAE N/A
- 52 Week Low
- XGN $1.30
- IAE $5.31
- 52 Week High
- XGN $6.22
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- XGN 74.82
- IAE 41.66
- Support Level
- XGN $5.60
- IAE $6.10
- Resistance Level
- XGN $6.22
- IAE $6.33
- Average True Range (ATR)
- XGN 0.48
- IAE 0.05
- MACD
- XGN 0.13
- IAE 0.00
- Stochastic Oscillator
- XGN 88.00
- IAE 26.09
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.